Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for October 17, 2007 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Channel Islands Alzheimer's Institute Receives $120,000 Donation
x-small text small text medium text large text


    /24-7PressRelease/ - CAMARILLO, CA - October 17, 2007 - The Channel Islands Alzheimer's Institute recently received a $120,000 donation from Cardax Pharmaceuticals. The money will be received in four payments of $30,000 each beginning now through 2008.

The Channel Islands Alzheimer's Institute is located on the campus of California State University Channel Islands.

Included in the $120,000 donation are at least two student research scholarships for $6,000 each to be used for the student recipients' fees and expenses over two semesters.

"We are gratified that Cardax Pharmaceuticals saw the potential in the drug discovery work of our institute," said Gilbert M. Rishton, Ph.D., founding scientist and director of the Channel Islands Alzheimer's Institute. "These funds will support our ongoing work in drug discovery for neurodegeneration and on the role that certain dietary antioxidants might play in the prevention of cognitive decline and Alzheimer's disease".

Cardax Pharmaceuticals, located in Aiea, Hawaii, develops antioxidant compounds as drug candidates for cardiovascular and inflammatory disease. Cardax Pharmaceuticals has identified a potent antioxidant found in krill and wild salmon, astaxanthin, as being effective in models of cardiovascular and inflammatory disease. The Cardax Pharmaceutical drug candidate is a novel and improved derivative of astaxanthin that is poised for human testing in 2008.

The Channel Islands Alzheimer's Institute has been created to conduct drug discovery research, potentially toward a treatment for the disease that has become so prevalent throughout the world today. According to the Alzheimer's Association, it is estimated that nearly 14 million people worldwide currently suffer from Alzheimer's Disease. By 2050, that number is expected to increase to 45 million. The Channel Islands Alzheimer's Institute will provide opportunities for faculty and students to discover new chemical compounds that will inhibit the neurodegenerative component of Alzheimer's disease.

For more information on the Channel Islands Alzheimer's Institute, its projects and science, contact Gilbert M. Rishton, founding scientist, by e-mail, gilbert.rishton@csuci.edu.

For media inquires about this donation or the Channel Islands Alzheimer's Institute contact Ceal Potts, communications specialist at CSUCI, 805-437-8940 or cecilia.potts@csuci.edu.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Gilbert M Rishton:
Other Press Release Headlines:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Gilbert M Rishton
Channel Islands Alzheimer's Inst

Director
One University Drive
Camarillo, CA
USA 93012
Voice: 310-924-9466
Fax: 000
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.